First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents

首次基于药效团鉴定雄激素受体下调剂:发现有效的抗前列腺癌药物

阅读:5
作者:Puranik Purushottamachar, Aakanksha Khandelwal, Pankaj Chopra, Neha Maheshwari, Lalji K Gediya, Tadas S Vasaitis, Robert D Bruno, Omoshile O Clement, Vincent C O Njar

Abstract

A qualitative 3D pharmacophore model (a common feature based model or Catalyst HipHop algorithm) was developed for well-known natural product androgen receptor down-regulating agents (ARDAs). The four common chemical features identified included: one hydrophobic group, one ring aromatic group, and two hydrogen bond acceptors. This model served as a template in virtual screening of the Maybridge and NCI databases that resulted in identification of six new ARDAs (EC(50) values 17.5-212 microM). Five of these molecules strongly inhibited the growth of human prostate LNCaP cells. These novel compounds may be used as leads to develop other novel anti-prostate cancer agents.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。